Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
54,034,651
-
Share change
-
-3,963,384
-
Total reported value
-
$18,938,016
-
Price per share
-
$0.35
-
Number of holders
-
39
-
Value change
-
-$1,453,778
-
Number of buys
-
9
-
Number of sells
-
16
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q4 2023
As of 31 Dec 2023,
RECRO PHARMA INC - COM (SCTL) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,034,651 shares.
The largest 10 holders included
First Light Asset Management, LLC, AWM Investment Company, Inc., DRIEHAUS CAPITAL MANAGEMENT LLC, ROYCE & ASSOCIATES LP, Samjo Management, LLC, VANGUARD GROUP INC, OV Management LLC, Caligan Partners LP, First Eagle Investment Management, LLC, and Alyeska Investment Group, L.P..
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.